Document is current
Any future updates will be listed below
-
Authors
Wang, Yan
Nan, Junjun
Hu, Yangchan
Meng, Yuxin
Wang, Bing
Ye, Zu
Chu, Xiaohe
Jing, Ji
Cheng, Xiangdong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China-Zhejiang Joint Fund for the Integration of Industrialization and Informatization (32271485)
the Natural Science Foundation of Zhejiang Province (YXD23H0302)
the National R&D Program of China (2024YFA0916703)
start-up fund from Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (2021QD11 to J.J.)
Zhejiang Key Laboratory of Prevention, Diagnosis, and Therapy of Digestive Tract Tumors (2024E10102)
Precision diagnosis and monitoring biosensing system for malignant tumors and other serious diseases (2021YFA0910100)
Combining the EMT model to screen and identify GC metastasis-related IncRNAs in peripheral blood exosomes and preliminary clinical application research (2019C03049)
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 20 January 2026
First Online: 5 February 2026
Declarations
:
: All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Chinese Academy of Sciences, Hangzhou Institute of Medicine (Ethics No. AP2024-08-0171). The animal experiments were performed in accordance with the guidelines of the Animal Care and Use Committee at the IACUC of the Chinese Academy of Sciences, Hangzhou Institute of Medicine. All participating patients signed informed consent forms, and the study was approved by the Shanghai Outdo Biotech Ethics Committee (ethical approval number: YB M-05-02).
: Not application.
: The authors declare no competing interests.
